LA Leche League International Inc
To help mothers worldwide to breastfeed through mother-to-mother support, encouragement, information and education, and to promote a better understanding of breastfeeding as an important element in the healthy development of the baby and the mother. Statistics LLLI provides over $33 million per year of in-kind services. LLLI reaches well over 300,000 people in 63 countries every month. Approximately 39,000 Leaders have been accredited in the past 44 years. Each LLL Group is attended by an average of 10 women per month, with many Groups attracting 20-30 mothers. LLLI's Center for Breastfeeding Information (CBI) contains more than 17,000 full-length research studies with more than 300 categories of breastfeeding data and adds over 125 new studies a month. The LLLI Board of Directors includes members from six countries. 7 LLLI maintains consultative status with the United Nations Children's Fund (UNICEF), official working relations with the World Health Organization (WHO), acts as a registered Private Voluntary Organization (PVO) for the Agency of International Development (USAID), is an accredited member of the US Healthy Mothers/Healthy Babies Coalition, and is a founding member of the World Alliance for Breastfeeding Action (WABA) LLLI is a member of the Child Survival Collaborations and Resources Group (CORE).
ICO
331045407
Web
Sign in to see organisation website
Traffic
360850
From Social media
News about from their social media (Facebook and X).
Data about organisation
Similar traffic
Organisations with similar web traffic to LA Leche League International Inc
Similar trafficJoin us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Exciting news from ITM! 🚀 Their Phase 3 COMPETE trial shows promising results for n.c.a. 177Lu-edotreotide, offering hope for patients with GEP-NETs. Together, we're witnessing advancements in healthcare that make a real difference! 💪💙 #CancerResearch #Hope #PositiveNews
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025
StreetInsider.com
Like CommentLast night marked a beautiful moment for Spanish football as Jenni Hermoso made her long-awaited return to the national team! 🇪🇸✨ It's inspiring to see talent and resilience shine through, reminding us all that new beginnings are always possible. #GoodNews #PositiveVibes
A night of debuts and 're-debuts' for Spain felt like the start of a new era under Bermudez
The New York Times
Like Comment